Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App<sup>NL</sup> <sup>-G-F</sup> Mice.

Glia·2026
Same author

Early Regional Microglial Remodelling in the Hippocampus of the App<sup>NL-G-F</sup> Alzheimer's Model.

Neuropathology and applied neurobiology·2026
Same author

Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling.

Journal for immunotherapy of cancer·2026
Same author

Th1 Cells Alter the Inflammatory Signature of IL-6 by Channeling STAT Transcription Factors to Alu-like Retroelements.

Journal of immunology (Baltimore, Md. : 1950)·2023
Same author

Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation.

Nature communications·2022
Same author

PIP2 depletion and altered endocytosis caused by expression of Alzheimer's disease-protective variant PLCγ2 R522.

The EMBO journal·2021
Same journal

Epidermal Dominance of Metabolically Constrained Immune Niches Underpins Immune Activation Signatures and Clinical Severity in Psoriatic Disease.

Immunology·2026
Same journal

Thymic APC Networks Orchestrate T-Cell Selection: Mechanisms and Therapeutic Opportunities in Immune Disorders.

Immunology·2026
Same journal

Immune Checkpoints in Leukaemia as Gatekeepers of Immuno-Modulation.

Immunology·2026
Same journal

Senescent Human Liver Endothelial Cells Mediate CD4<sup>+</sup> T Cell Recruitment via ICOSL.

Immunology·2026
Same journal

The Transcription Factor EGR2 Plays a Central Role in the Expansion and Function of TCRαβ<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> Double Negative T Cells in lpr Lupus Mice.

Immunology·2026
Same journal

Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.

Immunology·2026
See all related articles

Related Experiment Video

Updated: Nov 24, 2025

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

831

Macrophage reprogramming for therapy.

Valentina M T Bart1, Robert J Pickering2,3, Philip R Taylor1,4

  • 1Systems Immunity Research Institute, Cardiff University, Cardiff, UK.

Immunology
|December 28, 2020
PubMed
Summary
This summary is machine-generated.

Macrophages, key immune cells, offer new therapeutic targets for diseases like cancer and neurodegeneration. Reprogramming these cells shows promise for treating various disorders, presenting new opportunities and challenges in medicine.

Keywords:
macrophagespolarizationreprogramming

More Related Videos

Production and Characterization of Human Macrophages from Pluripotent Stem Cells
08:05

Production and Characterization of Human Macrophages from Pluripotent Stem Cells

Published on: April 16, 2020

17.2K
Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
06:38

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

30.3K

Related Experiment Videos

Last Updated: Nov 24, 2025

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

831
Production and Characterization of Human Macrophages from Pluripotent Stem Cells
08:05

Production and Characterization of Human Macrophages from Pluripotent Stem Cells

Published on: April 16, 2020

17.2K
Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
06:38

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

30.3K

Area of Science:

  • Immunology and cellular biology
  • Therapeutic strategies and disease intervention

Background:

  • Immune system dysfunction is central to numerous human diseases.
  • Current therapies often focus on T lymphocytes with limited success.
  • Macrophages are increasingly recognized as critical targets for disease management.

Purpose of the Study:

  • To review advancements in macrophage reprogramming for various disorders.
  • To discuss the therapeutic potential and challenges of targeting macrophages.

Main Methods:

  • Literature review of recent studies on macrophage biology and therapeutic strategies.
  • Analysis of macrophage origin, diversity, and function in health and disease.
  • Synthesis of current approaches for macrophage reprogramming.

Main Results:

  • Macrophages play vital roles in homeostasis and host defense.
  • Dysregulation of macrophages is implicated in cancer, neurodegeneration, autoimmunity, and metabolic diseases.
  • Emerging strategies for macrophage reprogramming offer novel therapeutic avenues.

Conclusions:

  • Targeting macrophages presents significant therapeutic opportunities across a spectrum of human diseases.
  • Further research is needed to overcome challenges and fully realize the potential of macrophage-based therapies.